Peak Bio, Inc. announced that it entered into a subscription agreement for private placement of 50,000 common shares at an issue price of $10 per share for gross proceeds of $500,000 on December 30, 2022. The company will also issue 46,500 warrants to purchase common shares, at an exercise price of $0.01 per share.